SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

by Batra Raj K, Huang Min, Zhu Li X, Hillinger Sven, Yang Seok-Chul, Sharma Sherven, Lin Jeff F, Burdick Marie D, Strieter Robert M, Dubinett Steven M
Published 2003-04-01